Skip directly to content

Apply - Inflamation


To be eligible for an investigator award, an applicant must hold an MD, PhD, PharmD or the equivalent and must reside in wider Europe, Israel, Turkey, Russia, Australia, New Zealand, Japan or South Korea.

How to Apply

Applications are to be submitted to Pfizer through an online submission website. Please click on the link below to be routed to Pfizer’s investigator-initiated research (IIR) website. Click on “Submit an IIR Request” and follow the online instructions. If this is your first time visiting the portal you must first “Create an Account”.

When asked if you are applying for a competitive grant program, select yes. Then, select the appropriate program name from the dropdown list.

Completed application must be accompanied by the following documents:

  • Synopsis or protocol in English on application template
    • Download RA clinical research application template here
    • Download IBD basic and translation research application template here
  • Abbreviated curriculum vitae (CV) (limited to 3 pages)
  • Budget for proposed research (link to template)
  • Cover letter on institution letterhead
  • Description of available laboratory facilities
  • Bibliography of relevant references


  • Listing of other research support available with a description of overlap and, if applicable, a listing of consenting collaborators (including CVs)


For online submission instructions click here

Tips for a successful application

To apply for a ASPIRE 2017 award click here

No other government, non-governmental, or industry-sponsored projects may cover the same work scope as the grant application to the ASPIRE Programme. However, a ASPIRE Programme grant may be related to other funding from foundations or government agencies, as long as there is no direct overlap. It is the responsibility of the applicant to justify the novelty of the proposal and provide evidence that the application does not overlap with any current or pending funding. Due to the competitive nature of these awards, Pfizer cannot provide any additional funding support beyond what has been requested and approved by the external independent review panel.


Coordinator e-mail address:

Date of preparation: May 2017
PP-XEL-EUR- 0520